“Rising Focus on Gene and Cell Therapies:”
The rise of personalized medicine and regenerative therapies is creating a shift in the global biologics virus filtration market. As gene and cell therapies become more prevalent, there is a growing focus on ensuring the safety and purity of these treatments. This has led to an increased emphasis on the development of tailored virus filtration solutions that are specifically designed to address the unique challenges of gene and cell therapy production. These therapies often involve complex biological processes that require higher levels of virus removal to avoid contamination and ensure patient safety. The growing complexity and specificity of gene and cell therapies have spurred the need for more advanced filtration technologies that can effectively handle these delicate and high-stakes treatments.
